Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Baxter
Farmers Insurance
QuintilesIMS
US Army
Johnson and Johnson
Harvard Business School
Merck

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,707,975

« Back to Dashboard

Summary for Patent: 5,707,975
Title: Oral formulations on an antifungal
Abstract:The present invention concerns a formulation for oral administration comprising an antifungal, a sufficient amount of a cyclodextrin or a derivative thereof, an aqueous acidic medium as bulk liquid carrier and an alcoholic co-solvent Addition of one or more pharmaceutically acceptable sweeteners and one or more pharmaceutically acceptable flavors thereto yields palatable oral formulations. A process of preparing such formulations and pharmaceutical dosage forms comprising said formulations.
Inventor(s): Fran.cedilla.ois; Marc Karel Jozef (Kalmthout, BE), Dries; Willy Maria Albert Carlo (Merksplas, BE)
Assignee: Janssen Pharmaceutica, N.V. (Beerse, BE)
Application Number:08/604,950
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Composition;

Drugs Protected by US Patent 5,707,975

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,707,975

PCT Information
PCT FiledSeptember 22, 1994PCT Application Number:PCT/EP94/03169
PCT Publication Date:April 06, 1995PCT Publication Number: WO95/08993

International Family Members for US Patent 5,707,975

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 630 ➤ Try a Free Trial
African Regional IP Organization (ARIPO) 9600792 ➤ Try a Free Trial
Austria 209916 ➤ Try a Free Trial
Australia 692180 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Queensland Health
Baxter
Dow
McKesson
Deloitte
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.